CN Patent

CN115605460A — 杂环化合物的合成

Assigned to Plexxikon Inc · Expires 2023-01-13 · 3y expired

What this patent protects

本文提供了可用于简便合成式2化合物的中间体和方法：其中R 1 是C(O)R 2 ；R 2 是任选地被1‑5个卤素取代的烷基；G是任选地被1‑2个R 3 取代的苯基或5‑6元杂芳基；并且每个R 3 独立地为C 1 ‑C 6 烷基、CN、C 1 ‑C 6 烷基‑CN、3‑6元环烷基或4‑6元杂环烷基。

USPTO Abstract

本文提供了可用于简便合成式2化合物的中间体和方法：其中R 1 是C(O)R 2 ；R 2 是任选地被1‑5个卤素取代的烷基；G是任选地被1‑2个R 3 取代的苯基或5‑6元杂芳基；并且每个R 3 独立地为C 1 ‑C 6 烷基、CN、C 1 ‑C 6 烷基‑CN、3‑6元环烷基或4‑6元杂环烷基。

Drugs covered by this patent

Patent Metadata

Patent number
CN115605460A
Jurisdiction
CN
Classification
—
Expires
2023-01-13
Drug substance claim
No
Drug product claim
No
Assignee
Plexxikon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.